Cargando…

Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021

BACKGROUND: Despite the increased emphasis on evidence-based medicine, the current state of evidence behind ophthalmology clinical practice guidelines is unknown. The purpose of this systematic analysis was to understand the levels of evidence (LOE) supporting American Academy of Ophthalmology (AAO)...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ailin, Lusk, Jay B., Kuo, Anthony N., Muir, Kelly W., Stinnett, Sandra S., Borkar, Durga S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067168/
https://www.ncbi.nlm.nih.gov/pubmed/37004018
http://dx.doi.org/10.1186/s12886-023-02866-9
_version_ 1785018409978691584
author Song, Ailin
Lusk, Jay B.
Kuo, Anthony N.
Muir, Kelly W.
Stinnett, Sandra S.
Borkar, Durga S.
author_facet Song, Ailin
Lusk, Jay B.
Kuo, Anthony N.
Muir, Kelly W.
Stinnett, Sandra S.
Borkar, Durga S.
author_sort Song, Ailin
collection PubMed
description BACKGROUND: Despite the increased emphasis on evidence-based medicine, the current state of evidence behind ophthalmology clinical practice guidelines is unknown. The purpose of this systematic analysis was to understand the levels of evidence (LOE) supporting American Academy of Ophthalmology (AAO) Preferred Practice Pattern (PPP) guidelines, assess changes over time, and compare LOE across ophthalmology subspecialties. METHODS: All current PPP guidelines and their immediate predecessors were comprehensively reviewed to identify all recommendations with LOE provided (I [randomized controlled trials], II [case–control or cohort studies], and III [nonanalytic studies]). RESULTS: Twenty-three out of 24 current PPPs had a prior edition. Among the PPPs with a prior edition, the number of recommendations with LOE decreased from 1254 in prior PPPs to 94 in current PPPs. The number of recommendations with LOE I decreased from 114 to 83, LOE II decreased from 147 to 2, and LOE III decreased from 993 to 9. However, the proportion of LOE I recommendations increased from 9 to 88%, driven by a disproportionate decrease in reporting of evidence lower than LOE I. Subgroup analysis by subspecialty showed similar trends (LOE I recommendations in prior PPPs vs current PPPs: retina: 57 [12%] vs 19 [100%]; cornea: 33 [5%] vs 24 [100%]; glaucoma: 9 [23%] vs 17 [100%]; cataract: 13 [17%] vs 18 [100%]). CONCLUSIONS: Trends in LOE reporting in PPP guidelines indicate an increasing emphasis on evidence from randomized controlled trials from 2012 to 2021. The decline in the number of recommendations with LOE reported suggests an area for improvement in future guidelines as the presence of LOE is crucial to facilitate interpretation of clinical practice guidelines.
format Online
Article
Text
id pubmed-10067168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100671682023-04-03 Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021 Song, Ailin Lusk, Jay B. Kuo, Anthony N. Muir, Kelly W. Stinnett, Sandra S. Borkar, Durga S. BMC Ophthalmol Research BACKGROUND: Despite the increased emphasis on evidence-based medicine, the current state of evidence behind ophthalmology clinical practice guidelines is unknown. The purpose of this systematic analysis was to understand the levels of evidence (LOE) supporting American Academy of Ophthalmology (AAO) Preferred Practice Pattern (PPP) guidelines, assess changes over time, and compare LOE across ophthalmology subspecialties. METHODS: All current PPP guidelines and their immediate predecessors were comprehensively reviewed to identify all recommendations with LOE provided (I [randomized controlled trials], II [case–control or cohort studies], and III [nonanalytic studies]). RESULTS: Twenty-three out of 24 current PPPs had a prior edition. Among the PPPs with a prior edition, the number of recommendations with LOE decreased from 1254 in prior PPPs to 94 in current PPPs. The number of recommendations with LOE I decreased from 114 to 83, LOE II decreased from 147 to 2, and LOE III decreased from 993 to 9. However, the proportion of LOE I recommendations increased from 9 to 88%, driven by a disproportionate decrease in reporting of evidence lower than LOE I. Subgroup analysis by subspecialty showed similar trends (LOE I recommendations in prior PPPs vs current PPPs: retina: 57 [12%] vs 19 [100%]; cornea: 33 [5%] vs 24 [100%]; glaucoma: 9 [23%] vs 17 [100%]; cataract: 13 [17%] vs 18 [100%]). CONCLUSIONS: Trends in LOE reporting in PPP guidelines indicate an increasing emphasis on evidence from randomized controlled trials from 2012 to 2021. The decline in the number of recommendations with LOE reported suggests an area for improvement in future guidelines as the presence of LOE is crucial to facilitate interpretation of clinical practice guidelines. BioMed Central 2023-03-31 /pmc/articles/PMC10067168/ /pubmed/37004018 http://dx.doi.org/10.1186/s12886-023-02866-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Song, Ailin
Lusk, Jay B.
Kuo, Anthony N.
Muir, Kelly W.
Stinnett, Sandra S.
Borkar, Durga S.
Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021
title Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021
title_full Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021
title_fullStr Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021
title_full_unstemmed Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021
title_short Systematic analysis of levels of evidence supporting American Academy of Ophthalmology Preferred Practice Pattern guidelines, 2012–2021
title_sort systematic analysis of levels of evidence supporting american academy of ophthalmology preferred practice pattern guidelines, 2012–2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067168/
https://www.ncbi.nlm.nih.gov/pubmed/37004018
http://dx.doi.org/10.1186/s12886-023-02866-9
work_keys_str_mv AT songailin systematicanalysisoflevelsofevidencesupportingamericanacademyofophthalmologypreferredpracticepatternguidelines20122021
AT luskjayb systematicanalysisoflevelsofevidencesupportingamericanacademyofophthalmologypreferredpracticepatternguidelines20122021
AT kuoanthonyn systematicanalysisoflevelsofevidencesupportingamericanacademyofophthalmologypreferredpracticepatternguidelines20122021
AT muirkellyw systematicanalysisoflevelsofevidencesupportingamericanacademyofophthalmologypreferredpracticepatternguidelines20122021
AT stinnettsandras systematicanalysisoflevelsofevidencesupportingamericanacademyofophthalmologypreferredpracticepatternguidelines20122021
AT borkardurgas systematicanalysisoflevelsofevidencesupportingamericanacademyofophthalmologypreferredpracticepatternguidelines20122021